Barclays’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.97M Sell
206,634
-2,214,558
-91% -$43.6M ﹤0.01% 1960
2025
Q4
$45.9M Buy
2,421,192
+994,474
+70% +$18.4M 0.02% 820
2025
Q3
$26.6M Buy
1,426,718
+766,740
+116% +$14.3M 0.01% 1062
2025
Q2
$12.2M Sell
659,978
-526,038
-44% -$9.33M ﹤0.01% 1436
2025
Q1
$20.7M Sell
1,186,016
-234,340
-16% -$3.95M 0.01% 1015
2024
Q4
$24.6M Buy
1,420,356
+741,959
+109% +$13.5M 0.01% 1010
2024
Q3
$12.6M Buy
678,397
+243,895
+56% +$4.11M 0.01% 1323
2024
Q2
$6.69M Sell
434,502
-200,578
-32% -$2.87M ﹤0.01% 1376
2024
Q1
$9.38M Sell
635,080
-61,804
-9% -$856K ﹤0.01% 1439
2023
Q4
$9.94M Buy
696,884
+538,674
+340% +$7.65M 0.01% 1518
2023
Q3
$2.21M Sell
158,210
-710,495
-82% -$9.09M ﹤0.01% 1836
2023
Q2
$10.2M Buy
868,705
+435,312
+100% +$4.96M 0.01% 981
2023
Q1
$4.98M Sell
433,393
-383,477
-47% -$4.74M 0.01% 1540
2022
Q4
$10.2M Buy
816,870
+36,711
+5% +$468K 0.01% 1199
2022
Q3
$10.2M Buy
780,159
+19,742
+3% +$292K 0.01% 851
2022
Q2
$10.6M Sell
760,417
-19,468
-2% -$260K 0.01% 991
2022
Q1
$11.6M Buy
779,885
+289,951
+59% +$3.97M 0.01% 860
2021
Q4
$6.63M Buy
489,934
+53,913
+12% +$763K ﹤0.01% 1514
2021
Q3
$6.42M Buy
436,021
+97,156
+29% +$1.64M ﹤0.01% 1457
2021
Q2
$6.17M Sell
338,865
-404,483
-54% -$7.2M 0.01% 1472
2021
Q1
$12.9M Buy
743,348
+407,036
+121% +$7.16M 0.01% 978
2020
Q4
$5.84M Sell
336,312
-33,113
-9% -$528K 0.01% 1431
2020
Q3
$5.09M Buy
369,425
+28,716
+8% +$422K 0.01% 1381
2020
Q2
$4.92M Buy
340,709
+203,962
+149% +$2.68M 0.01% 1394
2020
Q1
$1.49M Sell
136,747
-533,291
-80% -$9.83M ﹤0.01% 2554
2019
Q4
$14.3M Buy
670,038
+420,007
+168% +$9.4M 0.02% 1154
2019
Q3
$5.74M Sell
250,031
-38,971
-13% -$831K 0.01% 1728
2019
Q2
$5.69M Buy
289,002
+89,787
+45% +$1.75M 0.01% 1753
2019
Q1
$3.88M Buy
199,215
+84,125
+73% +$1.59M 0.01% 1880
2018
Q4
$1.9M Sell
115,090
-59,669
-34% -$1.2M ﹤0.01% 2464
2018
Q3
$4.04M Buy
174,759
+119,417
+216% +$2.71M 0.01% 2031
2018
Q2
$1.2M Sell
55,342
-98,244
-64% -$1.92M ﹤0.01% 3084
2018
Q1
$2.71M Buy
153,586
+112,305
+272% +$1.98M ﹤0.01% 2170
2017
Q4
$775K Buy
41,281
+25,838
+167% +$514K ﹤0.01% 3370
2017
Q3
$340K Buy
15,443
+7,656
+98% +$173K ﹤0.01% 3961
2017
Q2
$188K Sell
7,787
-37,235
-83% -$947K ﹤0.01% 4420
2017
Q1
$1.26M Sell
45,022
-1,285
-3% -$33.7K ﹤0.01% 2525
2016
Q4
$1.13M Buy
46,307
+2,929
+7% +$67.1K ﹤0.01% 2631
2016
Q3
$1.09M Sell
43,378
-2,731
-6% -$65.4K ﹤0.01% 2549
2016
Q2
$951K Buy
46,109
+35,624
+340% +$743K ﹤0.01% 2659
2016
Q1
$209K Buy
10,485
+4,116
+65% +$78.9K ﹤0.01% 3820
2015
Q4
$127K Sell
6,369
-818
-11% -$17.2K ﹤0.01% 4248
2015
Q3
$166K Sell
7,187
-15,303
-68% -$390K ﹤0.01% 4275
2015
Q2
$562K Sell
22,490
-40,837
-64% -$1.16M ﹤0.01% 3379
2015
Q1
$2.09M Buy
63,327
+4,409
+7% +$143K ﹤0.01% 2275
2014
Q4
$1.77M Sell
58,918
-279,173
-83% -$7.69M ﹤0.01% 2640
2014
Q3
$8.12M Buy
338,091
+301,791
+831% +$8.37M 0.02% 1349
2014
Q2
$1.02M Buy
36,300
+22,943
+172% +$667K ﹤0.01% 3322
2014
Q1
$361K Sell
13,357
-32,765
-71% -$900K ﹤0.01% 4226
2013
Q4
$1.2M Sell
46,122
-5,216
-10% -$134K ﹤0.01% 3187
2013
Q3
$1.18M Sell
51,338
-9,389
-15% -$231K ﹤0.01% 3166
2013
Q2
$1.59M Buy
+60,727
New +$1.75M ﹤0.01% 2801

Other funds holding SBRA